MedTrace Logo

Safety and Efficacy of the Olympus CADe System in Real-time Colonoscopy

NCT05943288 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 850

Last updated 2025-03-18

No results posted yet for this study

Summary

This is a prospective, multicenter, randomized Trial to assess the safety and efficacy of the Olympus Endoscopy Computer-Aided Detection (CADe) system, OIP-1, in the detection of colorectal neoplasia's during real-time colonoscopy. The aim of this system is to improve physician performance in the detection of potential mucosal abnormalities during colonoscopy performed for primary Colorectal Cancer screening or postpolypectomy surveillance.

Conditions

Interventions

DEVICE

OIP-1

Olympus Endoscopy Computer-Aided Detection (CADe) system

Sponsors & Collaborators

  • Cromsource

    collaborator INDUSTRY

  • Olympus Europe SE & Co. KG

    lead INDUSTRY

Principal Investigators

  • Karolin Boecker · Olympus Europa SE & Co. KG

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-25
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • Belgium
  • Germany
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05943288 on ClinicalTrials.gov